(Q73288560)
English
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome wit
scientific article published on 01 December 2000
Statements
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade (English)
E J Topol
1 reference
R M Califf
A M Lincoff
L Davidson-Ray
D B Mark
J E Tcheng
M V Bala
K M Anderson
J D Knight